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OBJECTIVES: This study investigated whether tissue Doppler imaging parameters, especially the peak systolic
velocity of the left ventricular lead-implanted segment (Ss), affect cardiac resynchronization therapy response.
METHODS: In this case-control study, 110 enrolled patients were divided into cases (responder group, n=65) and
controls (nonresponder group, n=45) based on whether their left ventricular end-systolic volume was reduced
by X15% at 6 months after surgery. Preoperative clinical and echocardiographic data were collected.
Multivariate logistic regression models were used to analyze the factors affecting the response to cardiac
resynchronization therapy, and receiver operating characteristic curves were plotted to evaluate their
diagnostic values.
RESULTS: The proportion of patients with left bundle branch block in the case group was higher than that in the
control group. The control group showed a higher left atrial volume index, E/A ratio and E/Em ratio but lower Ss
than that of the case group. A multivariate regression analysis showed that left bundle branch block, Ss, and an
E/Em ratio414 were independent risk factors affecting the response to cardiac resynchronization therapy.
Ss=4.1 cm/s was the best diagnostic threshold according to the receiver operating characteristic curve.
CONCLUSIONS: Ss is an important factor affecting the response to cardiac resynchronization therapy. Patients
with heart failure associated with Sso4.1 cm/s have a higher risk of nonresponse.
KEYWORDS: Cardiac Resynchronization Therapy; Heart Failure; Echocardiography; Tissue Doppler Imaging.
’ INTRODUCTION
With the recent accumulation of clinical evidence-based
data and the popularization of cardiovascular intervention
techniques, the number of patients with heart failure (HF)
receiving implanted cardiac resynchronization devices in
China has increased annually. In addition, the implantation
technique has gradually become available in primary-care
medical centers. However, despite strictly following the
inclusion criteria in the guidelines, approximately 30% of
recipients do not respond to cardiac resynchronization the-
rapy (CRT) (1). If the efficacy of CRT is assessed only using
the degree of left ventricular (LV) remodeling, then the
nonresponse rate is even higher (2). Therefore, quickly and
accurately identifying potential nonresponders to CRT before
surgery is of great clinical significance. Given the advantages
of noninvasive, easy-to-use techniques that are sensitive to
local myocardial motion and less affected by preloading,
tissue Doppler imaging (TDI) is widely used to diagnose and
treat cardiovascular diseases (3). Many clinical studies have
shown that in normal and HF populations, TDI-evaluated
myocardial tissue velocity (peak systolic [Sm], early diastolic
[Em], late diastolic [Am], and others) has a strong predictive
value for major adverse cardiovascular events (4-9). How-
ever, whether the aforementioned TDI parameters (especially
the myocardial tissue velocity of the segment containing the
LV lead implant) affect response to CRT remains unknown.
Thus, the present study conducted a retrospective case
analysis to investigate the relevant factors affecting response
to CRT and determine the parameters for ultrasound screen-
ing in clinical practice.
’ METHODS
The Institutional Review Board of the First Affiliated
Hospital of the University of Science and Technology of
China approved this retrospective observational study.DOI: 10.6061/clinics/2019/e1077
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Between August 2015 and December 2016, patients with
HF undergoing CRT at our hospital were included in this
study based on the following inclusion and exclusion criteria.
The inclusion criteria were (1) patients with New York Heart
Association (NYHA) Heart Function Class II to IV after
routine treatment; (2) sinus rhythm; (3) patients with left
bundle branch block (LBBB) and a QRS durationX130 ms or
without LBBB but with a QRS durationX150 ms; and (4) an
LV ejection fraction (LVEF) p35%. Patients were excluded
when they had (1) an upgraded or replaced pacemaker; (2)
quadripolar lead or multipoint pacing; (3) uncompleted heart
TDI examinations or poor-quality ultrasound images; (4) no
cardiac ultrasound data 6 months after surgery; or (5) right
bundle branch block (RBBB).
Baseline data including age, gender, height, weight, HF
etiology, NYHA classification, blood biochemistry profile
(creatinine and NT-proBNP levels), and therapeutic agents
were collected from the electronic medical records system.
Heart rate, QRS duration, and QRS morphology were eval-
uated using 12-lead ECG before surgery. LV lead position
was determined by reviewing the surgical notes.
The preoperative and 6-month postoperative echocardio-
graphic indices were evaluated using a Philips iE33 ultrasound
system with an X5-1 transducer (1-5 MHz). Ultrasound
examination was performed following the American Society
of Echocardiography (ASE) guidelines (10). Left atrial and LV
volumes were measured using Simpson’s biplane method and
indexed to body surface area. The left atrial volume index
(LAVI), LVend-diastolic volume index (LVEDVI), and LVend-
systolic volume index (LVESVI) were documented. Preopera-
tively, the mitral flow spectrum was acquired using pulse
Doppler imaging, and the peak early diastolic velocity (E) and
peak late diastolic velocity (A) were recorded. TDI was used to
obtain the myocardial velocity curves of the lateral and septal
mitral annulus and 12 LV segments (six basal and six middle
segments). Sm, Em, Am, mitral annular velocities, and the
peak systolic velocity of the LV lead-implanted segment (Ss)
were recorded (Figure 1). Intra- and interobserver reproduci-
bility for Ss were evaluated with regard to 20 randomly
selected patients and expressed as an intraclass correlation
coefficient (ICC). The intraobserver and interobserver ICCs
were 0.98 and 0.97, respectively.
A reduction X15% in LVESV 6 months after surgery was
defined as a response to CRT. Patients with or without a
response to CRTwere assigned to the case and control groups,
respectively.
Figure 1 - Example of myocardial velocity curve via tissue Doppler imaging. The sample was obtained from the left ventricular lead-
implanted segment (yellow circle); the Y-axis represents myocardial velocity (cm/s), and the X-axis represents time; Ss is the positive
peak on the curve.
Figure 2 - Study flow diagram.
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SPSS 22.0 was used for data analysis. Continuous variables
with normal distributions were expressed as means±standard
deviations. Continuous variables with nonnormal distribu-
tions were expressed as medians and interquartile ranges
(serum creatinine and NT-proBNP levels). Independent-
samples t-tests (variables with normal distributions) or
Mann-Whitney U tests (serum creatinine and NT-proBNP)
were used to compare between-group differences. Paired
Student’s t-tests were used to compare data within groups.
Categorical variables were expressed as frequencies and
percentages. The chi-square test or Mann-Whitney U test
(NYHA classification) was used to compare between-group
differences. Factors associated with significant differences
in the univariate analysis (po0.05) were included in the
multivariate logistic regression model. The backward stepwise
entry method (LR method) was used to screen relevant factors
affecting response to CRT. The receiver operating character-
istic (ROC) curve was used to evaluate the diagnostic value
of Ss in predicting response to CRT. The maximum value
of the Youden index was used as the optimal diagnostic
threshold to calculate sensitivity and specificity. A two-tailed
p-value of o0.05 was considered as significant.
’ RESULTS
Figure 2 shows the flow diagram of this study. Of the 159
patients with HF who received CRT at our hospital between
August 2015 and December 2016, 110 were included in this
study (mean age: 61.7±10.2 years; women: 30%; CRT-D:
72%) and were assigned to either the case group (65 patients,
59%) or the control group (45 patients).
The baseline data for the case and control groups are
shown in Table 1. No significant differences were found with
regard to gender, age, causes of HF, NYHA classification,
heart rate, QRS duration, serum creatinine level, NT-proBNP
level, echocardiographic indices (LVEDVI, LVESVI, LVEF, E,
A, Sm, Em and Am), medication regimen or LV lead position
between the two groups (p40.05 for all comparisons). The
proportion of patients with LBBB in the case group was
higher than that in the control group (72% vs. 42%,
w2=10.028, p=0.002). In addition, the control group showed
a higher LAVI, E/A ratio, and E/Em ratio but lower Ss than
the case group (po0.05 for all comparisons).
Table 2 and Figure 3 show the changes in echocardio-
graphic indices 6 months after surgery in both groups. Six
months after the surgery, the LAVI, LVEDVI, LVESVI, and
LVEF were significantly improved in the case group
(po0.001 for all comparisons), whereas only the LVEF was
improved in the control group (po0.001).
Table 3 shows the logistic regression analysis results.
Of the 15 factors included in the univariate analysis, LBBB,
the LAVI, E/A ratio, Ss, and an E/Em ratio 414 were
significantly associated with CRT response (po0.05 for all
comparisons). An additional multivariate regression analysis
showed that LBBB (OR: 4.193; 95% CIs: 1.697-10.361), Ss (OR:
1.548; 95% CIs: 1.078-2.222) and an E/Em ratio 414 (OR:
0.326; 95% CIs: 0.131-0.814) were independent risk factors
affecting CRT response. Because Ss might be affected by age,
age was included in the multivariate regression model.
However, the inclusion of age in the model did not lead to a
significant change (o10%) in the OR of Ss; therefore, the data
were not adjusted for age (11).
Table 1 - Baseline characteristics of patients.
Responders
(n=65)
Nonresponders
(n=45)
p-
value
Clinical parameters
Age, years 60.6±10.6 63.1±9.4 0.207
Female, n (%) 19 (29) 14 (31) 0.832
Ischemic etiology, n (%) 16 (25) 13 (29) 0.617
NYHA class, n (%) 0.581
II 12 (18) 9 (20)
III 35 (54) 26 (58)
IV 18 (28) 10 (22)
Heart rate (beats/min) 74.5±12.6 70.6±10.2 0.096
LBBB, n (%) 47 (72) 19 (42) 0.002
QRS duration, ms 163.3±20.3 160.7±18.3 0.486
Serum creatinine, mmol/l 89.0 (33.0) 83.0 (37.0) 0.481
NT-proBNP, pg/mL 1,825.0 (1,673) 2,274.0 (2,369.0) 0.091
Echocardiography
LAVI, ml/m2 42.4±17.0 52.8±19.7 0.004
LVEDVI, ml/m2 126.8±50.9 125.8±44.0 0.914
LVESVI, ml/m2 93.8±39.3 91.9±34.3 0.784
LVEF, % 26.2±4.5 27.2±5.6 0.290
Pulse Doppler
E, cm/s 71.4±21.5 80.3±31.0 0.068
A, cm/s 65.4±24.6 58.5±21.7 0.133
E/A ratio 1.3±0.6 1.6±0.9 0.031
Tissue Doppler
Ss, cm/s 5.1±1.5 4.2±1.4 0.001
Sm, cm/s 4.9±1.3 4.5±1.1 0.091
Em, cm/s 5.8±1.9 5.2±1.5 0.068
Am, cm/s 6.4±2.1 6.0±1.8 0.287
E/Em ratio 12.9±4.7 16.5±7.1 0.005
Medication
ACE-I or ARB, n (%) 58 (89) 41 (91) 1.000
b-Blocker, n (%) 57 (88) 36 (80) 0.272
Spironolactone, n (%) 60 (92) 42 (93) 1.000
LV pacing site 0.611
Anterolateral, n (%) 7 (11) 4 (9)
Lateral, n (%) 42 (65) 33 (73)
Posterolateral, n (%) 16 (25) 8 (18)
Values are n (%), mean±SD, or median (interquartile range).
ACE-I = angiotensin-converting enzyme inhibitor; ARB = angiotensin
receptor blockers; LAVI = left atrial volume index; LBBB = left bundle
branch block; LVEDVI = left ventricular end diastolic volume index; LVEF =
left ventricular ejection fraction; LVESVI = left ventricular end systolic
volume index; NYHA = New York Heart Association; RBBB = right bundle
branch block.
Table 2 - Echocardiographic characteristics of patients at baseline and follow-up.
Responders (n=65) Nonresponders (n=45)
Baseline Follow up Baseline Follow up
LAVI, ml/m2 42.4±17.0 34.5±15.1* 52.8±19.7 49.9±15.4
LVEDVI, ml/m2 126.8±50.9 107.0±43.3* 125.8±44.0 125.7±48.0
LVESVI, ml/m2 93.8±39.3 66.3±32.0* 91.9±34.3 89.4±35.7
LVEF, % 26.2±4.5 39.4±9.0* 27.2±5.6 29.9±6.2*
*po0.001, follow up vs. baseline; see Table 1 for abbreviations.
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Figure 4 shows the ROC curve for Ss predicting CRT
response. The area under the curve (AUC) was 0.736 (95%
CIs: 0.638-0.835), and Ss=4.1 cm/s was the best diagnostic
threshold for the ROC curve. The corresponding sensitivity,
specificity, positive predictive value (PPV), and negative
predictive value (NPV) were 80%, 64%, 77%, and 69%
respectively.
’ DISCUSSION
This study revealed that (1) preoperative LBBB, Ss, and an
elevated LV filling pressure (E/Em 414) were independent
risk factors affecting CRT response and that (2) patients
with HF with Ss o4.1 cm/s have a higher risk of non-
response to CRT.
Should TDI be used to assess the maximum difference in
time to peak systolic velocity or peak velocity? TDI has been
used to screen patients suitable for CRT. In most studies, LV
mechanical asynchrony was evaluated based on the peak
time difference measured via TDI. Previous single-center
studies with small sample sizes have also found that certain
ultrasound synchronic indicators (i.e., Ts-[lateral-septal],
12Ts-SD, PVD, and others) have predictive value for CRT
efficacy (12-14). However, even if examiners with uniform
training measure and analyze these indicators, the reprodu-
cibility of these measurements remains unsatisfactory. It is
also difficult for the sensitivity and specificity of the indicators
to meet the requirements of extensive clinical application.
Therefore, a prospective, multicenter study (PROSPECT) did
not recommend using the above ultrasound synchronization
indices as screening criteria for CRT (2).
This result is not surprising because the greatest advantage
of TDI is its sensitivity to local myocardial motion (9),
whereas it is relatively insensitive to whole heart movement.
Figure 3 - Changes in echocardiographic parameters in responder and nonresponder groups.
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Many evidence-based clinical studies have shown that in
either normal or HF populations, TDI-evaluated myocardial
tissue velocity (Sm, Em, Am, and so on) has a strong
predictive value for major adverse cardiovascular events
(e.g., cardiovascular death, nonfatal myocardial infarction
and HF exacerbation) (4-9). It remains unclear whether the
aforementioned indicators can be used to assess CRT efficacy
in populations with moderate-to-severe HF. This study
revealed that Ss is an independent risk factor affecting CRT
response and that patients with Ss o4.1 cm/s might have a
higher risk of nonresponse to CRT. Moreover, the tradition-
ally used indicators (e.g., Sm, Em, and Am) have no
significant predictive value for CRT response. The LV lead
position is the key to determining CRT efficacy. A reduced Ss
reflects a decrease in the myocardial viability in this region,
suggesting the presence of local ischemia, fibrosis, or scars
(15,16) that affect the benefits of CRT. This finding cannot be
achieved via the assessment of myocardial motion at the
mitral annulus, which is distant from the lead. This study
also suggests that surgeons should avoid implanting LV
leads in regions with Sso4.1 cm/s. If avoiding these areas is
impossible because of variant target veins, then quadripolar
LV leads, LV multipoint pacing, or LV intracardiac pacing
should be used to ‘‘bypass’’ the low-viability region of the
myocardium to help increase CRT response rates.
In this study, preoperative LBBB and E/Em 414 were
independent risk factors affecting CRT response. Both QRS
duration and QRS morphology are important factors
affecting CRT efficacy (17). However, this study found that
only LBBB morphology affects the benefit of CRT. The
reasons for this result might be related to the patients with
HF included in this study because they had wide QRS waves
(baseline QRSd=162 ms) according to the guideline criteria;
therefore, an additional increase in QRS duration cannot
significantly increase CRT response rate. Biagio Sassone et al.
(18) also reported that a baseline QRSd 4178 ms is asso-
ciated with a lower CRT response rate. A 10-year prospec-
tive, multicenter study by Gasparini et al. (19) included 3,319
patients undergoing CRT and found that a baseline QRSd
^200 ms was associated with an increased risk of all-cause
and cardiac mortality.
The E/Em ratio is a robust indicator of LV filling pressure
in ultrasound assessment. An E/Em ratio 414 is highly
specific, indicating increased LV filling pressure (3), which
signifies a worsening hemodynamic state, increased heart
transplant rate, and higher mortality among patients with
HF; hence, it is a strong predictor of poor prognosis (20,21).
In this study, increased LV filling pressure was also a risk
factor for nonresponse to CRT. This finding is consistent with
Ciampi Q et al. (22), which further validates the results of our
previous study (23).
Limitations
This study has the following limitations. (1) It was
designed as a case-control study and included consecutive
patients treated in our hospital; however, selection bias is
difficult to avoid, and our conclusions must be further
verified by prospective studies. (2) Patients implanted with
quadripolar leads or MPP were excluded because the
variability in pacing sites made it difficult to measure Ss.
(3) Speckle-tracking technology can detect more abundant
myocardial motion patterns (including longitudinal, radial,
and toroidal motion) and might help increase CRT response
Table 3 - Univariate and multivariate logistic regression analyses: Estimates of the correlations between baseline clinical and
echocardiographic characteristics and CRT response.
Parameter Univariate Multivariate
OR (95% CIs) p-value OR (95% CIs) p-value
Age, years 0.975 (0.939-1.014) 0.207
Female 0.915 (0.400-2.091) 0.832
Ischemic etiology 0.804 (0.341-1.893) 0.617
NYHA class IV 1.340 (0.551-3.259) 0.518
LBBB 3.573 (1.600-7.977) 0.002 4.193 (1.697-10.361) 0.002
QRS duration, ms 1.007 (0.987-1.028) 0.484
NT-proBNP, pg/mL 1.000 (1.000-1.000) 0.197
LAVI, ml/m2 0.969 (0.948-0.991) 0.006
E, cm/s 0.985 (0.970-1.000) 0.056
E/A ratio 0.547 (0.321-0.933) 0.027
Ss, cm/s 1.682 (1.190-2.376) 0.003 1.548 (1.078-2.222) 0.018
Sm, cm/s 1.335 (0.952-1.873) 0.094
Em, cm/s 1.247 (0.980-1.587) 0.073
E/Em ratio414 0.366 (0.165-0.814) 0.014 0.326 (0.131-0.814) 0.016
LV pacing site 1.177 (0.590-2.351) 0.643
OR = odds ratio; CIs = confidence intervals; see Table 1 for additional abbreviations.
Figure 4 - Receiver operating characteristic (ROC) curve of Ss to
predict CRT response.
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rates (24). However, speckle-tracking technology requires
specific equipment, highly skilled examiners, and profes-
sional software for offline analysis; thus, it is difficult to
extensively use this technology in primary-care medical
centers. This study aimed to determine a rapid preoperative
screening indicator for medical centers at all tiers; therefore,
speckle-tracking technology was not applied. (4) The reduc-
tion of myocardial velocity assessed via TDI can only indi-
cate decreases in myocardial viability in the corresponding
region. This study did not use cardiac magnetic resonance or
cardiac PET to further investigate the reasons underlying
reduced myocardial viability.
’ CONCLUSIONS
In summary, the present study showed that preoperative
LBBB, Ss, and elevated LV filling pressure are independent
risk factors that affect CRT response. Furthermore, patients
with HF with Ss o4.1 cm/s have a higher risk of not res-
ponding to CRT. Therefore, surgeons should avoid implant-
ing the LV lead in segments with significant Ss reduction to
increase CRT response rate.
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